Medyra Pharmaceutical

Olaparib is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults.

Dasatinib is a targeted cancer therapy belonging to the class of tyrosine kinase inhibitors (TKIs). It is used to treat certain types of leukemia by blocking the activity of abnormal proteins that signal cancer cells to multiply. Dasatinib tablets contain the active ingredient Dasatinib, which inhibits multiple tyrosine kinases, including BCR-ABL and members of the SRC family.

Crizalk 250 mg Capsule is a prescription medication primarily used in the treatment of certain types of lung cancer.

Veenat 400 mg Tablet is a prescription medication that contains Imatinib Mesylate (400 mg) as its active ingredient. It is primarily used as an anti-cancer (chemotherapy) and anti-leukemia drug.

Soliris (Eculizumab) Injection is a monoclonal antibody medication used to treat several rare and serious disorders that involve abnormal activation of the complement system — part of the body’s immune defense mechanism.

Ceritinib is an orally administered small-molecule inhibitor of anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase involved in the development and progression of certain cancers. It is primarily used in the treatment of ALK-positive non-small cell lung cancer (NSCLC).